Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
Jiao Huang, Wai Ying Tsang, Xiaona Fang, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 855-871
Closed Access | Times Cited: 21

Showing 21 citing articles:

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Tumor Microenvironment and Cancer Metastasis
Yulong Li, Han Wu
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 4
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy
Siyuan Jia, Ann M. Bode, Xue Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189166-189166
Closed Access | Times Cited: 4
Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies
Ying Wang, Haoyuan Ma, Bowen Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Clonorchis sinensis Promotes Intrahepatic Cholangiocarcinoma Progression by Activating FASN‐Mediated Fatty Acid Metabolism
Xiaoxue Ren, Yanqing Wu, Tongtong Song, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Advances in Palmitoylation: A key Regulator of liver cancer development and therapeutic targets
Zilong Zhu, Shenghui Feng, Anqi Zeng, et al.
Biochemical Pharmacology (2025), pp. 116810-116810
Closed Access
Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma
Muqi Liu, Linzhe Li, Lu Cao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010947-e010947
Open Access
Advances in targeting protein S-palmitoylation in tumor immunity and therapy
Miaomiao Han, Yuanhao Lv, Yiyang Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Epigenetic nanoplatform for synergistic immune activation and immunogenicity restoration enhancing cancer radio-immunotherapy
Zhenhu He, Xiaopei Peng, Jiong Li, et al.
Chemical Engineering Journal (2025), pp. 161177-161177
Closed Access
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
EMBO Molecular Medicine (2025)
Open Access
Drug functional remapping: a new promise for tumor immunotherapy
Jiayi Dong, Ting Su, Jun Wu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Glioblastoma cells secrete ICAM1 via FASN signaling to promote glioma-associated macrophage infiltration
Wenxin Zhang, Jialin Wang, Jiayu Ji, et al.
Cellular Signalling (2025), pp. 111823-111823
Closed Access
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity
Elisabet Cuyàs, Stefano Pedarra, Sara Verdura, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy
Sofia La Vecchia, Simona Fontana, Iris C. Salaroglio, et al.
Cancer Letters (2024) Vol. 604, pp. 217221-217221
Open Access | Times Cited: 2
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
R. Rosell, Eloísa Jantus‐Lewintre, Peng Cao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy
Di Ye, Shuang Zhou, Xinyu Dai, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189161-189161
Closed Access | Times Cited: 1
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity
Mario Cioce, Mariamena Arbitrio, Nicoletta Polerà, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Metabolic and Epigenetic Mechanisms in Hepatoblastoma: Insights into Tumor Biology and Therapeutic Targets
Yuanji Fu, Raquel Francés, Claudia Monge, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1358-1358
Open Access
Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer
Zhijie Xu, Yunfei Wu, Yanfeng Bai, et al.
Surgery (2024), pp. 108926-108926
Closed Access
Page 1

Scroll to top